Ballentine Partners’s Erasca ERAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$259K Buy
14,132
+128
+0.9% +$1.83K ﹤0.01% 875
2026
Q1
$227K Buy
14,004
+8
+0.1% +$95 ﹤0.01% 873
2025
Q4
$52.1K Hold
13,996
﹤0.01% 991
2025
Q3
$30.5K Sell
13,996
-1,773
-11% -$2.82K ﹤0.01% 1012
2025
Q2
$20K Buy
+15,769
New +$21.1K ﹤0.01% 985

Other funds holding ERAS

Ballentine Partners's ERAS Position: Q2 2026 in Review

Ballentine Partners increased its Erasca (ERAS) stake by 0.91% in Q2 2026, buying an estimated $1.83K and bringing the position to 14,132 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #875.

Ballentine Partners first reported a position in ERAS in Q2 2025 and has held it in 5 quarters since. 257 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • Ballentine Partners held 14,132 shares of Erasca worth $259K as of Q2 2026.
  • Ballentine Partners bought 128 Erasca shares in Q2 2026, an estimated $1.83K.
  • Erasca made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #875 holding.
  • Ballentine Partners first reported a position in Erasca in Q2 2025 and has held it in 5 quarters since.
  • 257 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.